The effects of methylprednisolone on complement, immunoglobulins and pulmonary neutrophil sequestration during cardiopulmonary bypass

Vascular

Volumn 7, Issue 4, 1999, Pages 414-418

  Dernek, Sadettin ^a   Tünerir, Bülent ^a   Sevin, Behçet ^a   Aslan, Recep ^a   Uyguç, Ozer ^a   Kural, Tuğrul ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

cardiopulmonary bypass; complement; immunoglobulin; methylprednisolone; neutrophil sequestration

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C4; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; PROTAMINE;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HEART VALVE REPLACEMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG SEQUESTRATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; WOUND CLOSURE;

ADULT; ANTI-INFLAMMATORY AGENTS; AORTIC VALVE; BRONCHOPULMONARY SEQUESTRATION; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C4; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; IMMUNOGLOBULINS; INJECTIONS, INTRAVENOUS; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MITRAL VALVE; NEUTROPHILS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; REFERENCE VALUES; RHEUMATIC HEART DISEASE; TREATMENT OUTCOME;

EID: 0345620963     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099900700405     Document Type: Article

References (26)

1. Cavarocchi N. C., Pluth J. R., Schaff H. V., et al, Complement activation during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 1986, 91, 252–258.
2. Rent R., Ertel N., Eisenstein R., Gewurz H., Complement activation by interaction of polyanions and polycations I. Heparin protamine-induced consumption of complement. Journal of Immunology, 1975, 114, 120–124.
3. Kirklin J. K., Chenoweth D. E., Naftel B. C., Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Annals of Thoracic Surgery, 1986, 41, 193–199.
4. Best N., Sinosich M. J., Teisner B., et al, Complement activation during cardiopulmonary bypass by heparin-protamine interaction. British Journal of Anaesthesiology, 1984, 56, 339–343.
5. Aslan R., Tünerir B., Dernek S., et al, The factors affecting complement activation in open heart surgery. Journal of Cardiovascular Surgery, 1992, 33, 754–760.
6. Parker D. J., Cantrell J. W., Karp R. B., et al, Changes in serum complement and immunoglobulins following CPB. Surgery, 1972, 71, 824–827.
7. Hammerschmidt D. E., Stroncek D. F., Bowers T. K., et al, Complement activation and neutropenia occurring during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 1981, 81, 370–377.
8. Tennenberg S. D., Bailey W. W., Cotta L. A., et al, The effects of methyl prednisolone on complement-mediated neutrophil during cardiopulmonary bypass. Surgery, 1986, 100, 134–142.
9. Chenoweth D. E., Cooper S. W., Hugli T. E., et al, Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. New England Journal of Medicine, 1981, 304, 497–502.
10. Chiu R. S. C., Samson R., Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia and protamine administration. Annals of Thoracic Surgery, 1984, 37, 229–232.
11. Kirklin J. K., Westaby S., Blackstone E. H., et al, Complement and damaging effects of cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 1983, 86, 845–857.
12. Haslam P. L., Townsend P. J., Branthwaite M. A., Complement activation during cardiopulmonary bypass. Anaesthesia, 1980, 35, 22–26.
13. Jones H. M., Matthews N., Vaughan R. S., Stark J. M., Cardiopulmonary bypass and complement activation. Anaesthesia, 1982, 37, 629–633.
14. Cavarocchi N. C., England M. D., Schaff H. V., et al, Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation. Circulation, 1986, 74, 130–133.
15. Siegel J., Rent R., Gewurz H., Interaction of C reactive protein with the complement system. Protamine induced consumption of complement in acute phase sera. Journal of Experimental Medicine, 1974, 140, 631–647.
16. Borelassa P. H., Shifferli A., Zalmi F., et al, Perioperative changes in complement associated with cardiopulmonary bypass. British Journal of Anaesthesiology, 1982, 54, 1047–1049.
17. Cavarocchi N. C., Schaff H. V., Orszulak T. A., et al, Evidence for complement activation by protamine—heparin interaction after cardiopulmonary bypass. Surgery, 1985, 98, 525–531.
18. White J. V., Complement activation during cardiopulmonary bypass. New England Journal of Medicine, 1981, 305, 51–55.
19. Weir D. M., Immunology, 5th edn. Churchill Livingstone, Edinburgh, UK, 1983, pp. 22–23.
20. Lozano R., Navarro M., Suarez J., et al, Intraoperative changes of immunoglobulins and complement fraction during open-heart surgery using membrane oxygenators. Journal of Cardiovascular Surgery, 1981, 22, 261–265.
21. Hammerschmidt D. E., Weave L. J., Hudson L. D., et al, Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet, 1980, 1, 947–949.
22. Ognibene F. P., Martin S. E., Parker M. M., et al, Adult respiratory distress syndrome in patients with severe neutropenia. New England Journal of Medicine, 1986, 315, 547–551.
23. Hosea S., Brown E., Hammer E., Frank M., Role of complement activation in a model of adult respiratory distress syndrome. Journal of Clinical Investigation, 1980, 66, 375–382.
24. Solomkin J. S., Cotta L. A., Saton P. S., et al, Complement activation and clearance in acute illness and injury: Evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man. Surgery, 1985, 97, 668–678.
25. Hammerschmidt D. E., White J. G., Craddock P. R., et al, Corticosteroid inhibit complement-induced granulocyte aggregation. Journal of Clinical Investigation, 1979, 63, 798–801.
26. Packard B. D., Weiler J. M., Steroid inhibit activation of the alternate-amplification pathway of complement. Infections and Immunology, 1983, 40, 1011–1015.